DK0975640T3 - Antimitotiske halogenderivater af vinka-alkaloider - Google Patents

Antimitotiske halogenderivater af vinka-alkaloider

Info

Publication number
DK0975640T3
DK0975640T3 DK98920607T DK98920607T DK0975640T3 DK 0975640 T3 DK0975640 T3 DK 0975640T3 DK 98920607 T DK98920607 T DK 98920607T DK 98920607 T DK98920607 T DK 98920607T DK 0975640 T3 DK0975640 T3 DK 0975640T3
Authority
DK
Denmark
Prior art keywords
antimitotic
halogen derivatives
formula
preparation
vinka alkaloids
Prior art date
Application number
DK98920607T
Other languages
Danish (da)
English (en)
Inventor
Alain Duflos
Jacques Fahy
Du Boulay Valerie Thillaye
Jean-Marc Barret
Bridget Hill
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK0975640T3 publication Critical patent/DK0975640T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98920607T 1997-04-10 1998-04-10 Antimitotiske halogenderivater af vinka-alkaloider DK0975640T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Publications (1)

Publication Number Publication Date
DK0975640T3 true DK0975640T3 (da) 2004-11-01

Family

ID=9505731

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98920607T DK0975640T3 (da) 1997-04-10 1998-04-10 Antimitotiske halogenderivater af vinka-alkaloider
DK06124480.2T DK1764368T3 (da) 1997-04-10 1998-04-10 Antimototisk halogeneret derivat af vincaalkaloid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06124480.2T DK1764368T3 (da) 1997-04-10 1998-04-10 Antimototisk halogeneret derivat af vincaalkaloid

Country Status (15)

Country Link
US (1) US6127377A (enExample)
EP (3) EP1764368B1 (enExample)
JP (3) JP4401440B2 (enExample)
AT (2) ATE473987T1 (enExample)
AU (1) AU737549C (enExample)
BR (2) BR9816177B1 (enExample)
CA (3) CA2665949C (enExample)
CY (2) CY1111476T1 (enExample)
DE (3) DE69824840T2 (enExample)
DK (2) DK0975640T3 (enExample)
ES (2) ES2222588T3 (enExample)
FR (2) FR2761990B1 (enExample)
LU (1) LU91769I2 (enExample)
PT (2) PT1764368E (enExample)
WO (1) WO1998045301A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) * 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
NZ547370A (en) * 2003-12-04 2010-09-30 Amr Technology Inc Vinca derivatives
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
CA2607940C (en) 2005-05-18 2009-12-15 Aegera Therapeutics Inc. Bir domain binding compounds
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
MY159563A (en) 2006-05-16 2017-01-13 Pharmascience Inc Iap bir domain binding compounds
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
NZ602368A (en) 2010-02-12 2014-10-31 Pharmascience Inc Iap bir domain binding compounds
US8940754B2 (en) 2010-02-22 2015-01-27 The Scripps Research Institute 10′-fluorinated Vinca alkaloids provide enhanced biological activity against MDR cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
ATE270297T1 (de) 2004-07-15
CA2665949C (fr) 2013-06-11
JP2009167196A (ja) 2009-07-30
AU737549B2 (en) 2001-08-23
DE69824840T2 (de) 2005-07-21
DE69824840D1 (de) 2004-08-05
EP1357125A2 (fr) 2003-10-29
JP2001518892A (ja) 2001-10-16
CA2455416A1 (fr) 1998-10-15
DE69841766D1 (de) 2010-08-26
PT1764368E (pt) 2010-09-16
JP4401440B2 (ja) 2010-01-20
FR2761990A1 (fr) 1998-10-16
US6127377A (en) 2000-10-03
BR9807944B1 (pt) 2011-02-08
CA2286560C (fr) 2009-09-08
WO1998045301A1 (fr) 1998-10-15
CY2010019I2 (el) 2012-01-25
JP4307292B2 (ja) 2009-08-05
LU91769I2 (fr) 2011-02-22
FR2761990B1 (fr) 1999-06-25
ES2222588T3 (es) 2005-02-01
PT975640E (pt) 2004-11-30
CY1111476T1 (el) 2012-01-25
BR9816177B1 (pt) 2010-08-24
CA2286560A1 (fr) 1998-10-15
AU737549C (en) 2002-03-28
EP0975640B1 (fr) 2004-06-30
DE122010000054I1 (de) 2011-05-05
FR10C0045I2 (fr) 2011-04-29
ES2347878T3 (es) 2010-11-22
EP1357125A3 (fr) 2003-11-26
DK1764368T3 (da) 2010-10-18
AU7340898A (en) 1998-10-30
EP0975640A1 (fr) 2000-02-02
EP1764368B1 (fr) 2010-07-14
CA2665949A1 (fr) 1998-10-15
CA2455416C (fr) 2010-11-02
CY2010019I1 (el) 2012-01-25
FR10C0045I1 (enExample) 2010-10-29
ATE473987T1 (de) 2010-07-15
JP2004277418A (ja) 2004-10-07
BR9807944A (pt) 2000-03-08
EP1764368A1 (fr) 2007-03-21

Similar Documents

Publication Publication Date Title
FR10C0045I2 (fr) Derive halogene antimitotique d'alcaloide de vinca
SE7508332L (sv) Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel.
ES532836A0 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
KR870010027A (ko) 벤조티아지논 유도체의 제조 방법
ATE44742T1 (de) Verfahren zur herstellung von ergoline n-methyl- derivaten.
HUT40090A (en) New process for production of derivatives of hh-1,2,4-triasole
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
NO873131L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8-(lavere alkyl)-bicyclo-(4.2.0)-octanderivater.
JPS5564592A (en) Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
JPS5718680A (en) Indole derivative
ES483303A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
KR840009112A (ko) 세펨화합물의 제조방법
JPS5246097A (en) Method of preparing pyrrlobenzodiazpins or acid addition salts thereof
JPS51146497A (en) Process for preparing pyrido (1,2-a)pyrimidinone derivatives
JPS57183791A (en) Imidazopyrazine derivative
JPS51113890A (en) Method for preparing novel cephalosporins
JPS5634674A (en) Isoxazolin-3-one derivative
JPS54138600A (en) Benzo-azabicyclo3,3,1-nonane derivative
AT356116B (de) Verfahren zur herstellung neuer derivate des pyrrolo-(1,2-a) (1,4)-diazepines und deren salzen
JPS52142066A (en) Isooxazolium salts and their preparation